AI helps Stanford scientists discover a "natural Ozempic" with a surprising advantage

Stanford researchers used AI to identify a natural molecule called BRP that suppressed appetite and promoted fat loss in animal studies, reducing food intake by up to 50%. The molecule targets a different brain pathway and could offer an Ozempic-like obesity treatment without common digestive side effects or significant muscle loss, if future human trials prove successful.

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.